Trial deaths prompt tighter rules.
Macilwain
C
C
D000998:Antiviral Agents / Q000009:adverse effects; D001086:Arabinofuranosyluracil / Q000009:adverse effects / Q000031:analogs & derivatives; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence* / Q000592:standards; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D001086:Arabinofuranosyluracil; C043457:fialuridine